Gapping up
In reaction to strong earnings/guidance: GURE +15.4%, ALRM +11.5%, HCKT +9.9%, OPXA +9.2%, (also announces 'supportive' preclinical study results for its Neuromyelitis Optica program), OPWR +5.9%, LITE +5.4%, (also files to delay Form 10-Q ), ARNA +5.3%, JNP +4.3%, UQM +3.4%, WGBS +2.5%, TSEM +2%, LXFT +1.9%, HTHT +1.5%, JOBS +1.5%, GIB +1.4%, OXGN+0.9%
M&A news: MEG +3.3% (Media General is near a decision to support Nexstar's (NXST) pending bid to acquire MEG, according to Bloomberg)
Select Brazil related names showing strength: VIV +3.7%, TSU +3.4%, SBS +3%, ABEV +2.6%, VALE +1.7%, PBR +1.4%
Other news: ANFI +30% (announces the completion of the Independent Third Party Forensic Investigation, BDO has independently concluded that these allegations are 'unsubstantiated and/or unfounded' ), AMDA +20% (submitted 24-month clinical data outcomes from its CASCADE study to the FDA), MNKD +8.3% (rebounding following yesterday's declines), JCP +6.7% (announces Q3 SSS +6.4%, and that gross margins and earnings exceeded their expectationsreaches agreement to settle a false advertising class action lawsuit in California), LITE +5.4% (filed to delay Form 10-Q in connection with separation from JDS Uniphase), JMEI +3% (may attributed to Singles Day in China), AVXL +2.9% (confirms the positive safety and cognitive efficacy data from its Phase 2a Alzheimer's trial of ANAVEX 2-73; no change to science, data or fundamentals of the company), RDY +2.9% (rebounding pre-mkt after yday's declines), EDU +2.7% (may attributed to Singles Day in China), SUNE +2.3% (rebounding pre-mkt after yday's declines), QIHU +1.8% (still checking), DEO +1.4% (may be in sympathy with M&A deals in spirit space),NGG +1.3% (appoints Deloitte as its new auditor, replacing PricewaterhouseCoopers), BABA +1.2% (reports that $10 bln of GMV settled through Alipay on 'Singles Day'; exceeds 2014 levels after 14 hrs), WX +1% (WuXi PharmaTech and Eli Lilly (LLY) announce strategic collaboration to develop, manufacture and commercialize a novel small molecule in China)
Analyst comments: AEGR +0.6% (upgraded to Neutral from Underperform at BofA/Merrill), AMZN +0.6% (target raised to $800 from $750 at Morgan Stanley
)
In reaction to strong earnings/guidance: GURE +15.4%, ALRM +11.5%, HCKT +9.9%, OPXA +9.2%, (also announces 'supportive' preclinical study results for its Neuromyelitis Optica program), OPWR +5.9%, LITE +5.4%, (also files to delay Form 10-Q ), ARNA +5.3%, JNP +4.3%, UQM +3.4%, WGBS +2.5%, TSEM +2%, LXFT +1.9%, HTHT +1.5%, JOBS +1.5%, GIB +1.4%, OXGN+0.9%
M&A news: MEG +3.3% (Media General is near a decision to support Nexstar's (NXST) pending bid to acquire MEG, according to Bloomberg)
Select Brazil related names showing strength: VIV +3.7%, TSU +3.4%, SBS +3%, ABEV +2.6%, VALE +1.7%, PBR +1.4%
Other news: ANFI +30% (announces the completion of the Independent Third Party Forensic Investigation, BDO has independently concluded that these allegations are 'unsubstantiated and/or unfounded' ), AMDA +20% (submitted 24-month clinical data outcomes from its CASCADE study to the FDA), MNKD +8.3% (rebounding following yesterday's declines), JCP +6.7% (announces Q3 SSS +6.4%, and that gross margins and earnings exceeded their expectationsreaches agreement to settle a false advertising class action lawsuit in California), LITE +5.4% (filed to delay Form 10-Q in connection with separation from JDS Uniphase), JMEI +3% (may attributed to Singles Day in China), AVXL +2.9% (confirms the positive safety and cognitive efficacy data from its Phase 2a Alzheimer's trial of ANAVEX 2-73; no change to science, data or fundamentals of the company), RDY +2.9% (rebounding pre-mkt after yday's declines), EDU +2.7% (may attributed to Singles Day in China), SUNE +2.3% (rebounding pre-mkt after yday's declines), QIHU +1.8% (still checking), DEO +1.4% (may be in sympathy with M&A deals in spirit space),NGG +1.3% (appoints Deloitte as its new auditor, replacing PricewaterhouseCoopers), BABA +1.2% (reports that $10 bln of GMV settled through Alipay on 'Singles Day'; exceeds 2014 levels after 14 hrs), WX +1% (WuXi PharmaTech and Eli Lilly (LLY) announce strategic collaboration to develop, manufacture and commercialize a novel small molecule in China)
Analyst comments: AEGR +0.6% (upgraded to Neutral from Underperform at BofA/Merrill), AMZN +0.6% (target raised to $800 from $750 at Morgan Stanley
)